Detalhe da pesquisa
1.
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses.
Cell
; 185(6): 995-1007.e18, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35303429
2.
Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization.
Cell
; 178(4): 1004-1015.e14, 2019 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31398326
3.
A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus.
Proc Natl Acad Sci U S A
; 120(34): e2304876120, 2023 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37590417
4.
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
J Infect Dis
; 214(suppl 3): S210-S217, 2016 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27587634
5.
Development of Prototype Filovirus Recombinant Antigen Immunoassays.
J Infect Dis
; 212 Suppl 2: S359-67, 2015 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26232440
6.
Demonstration of the Pre-Emergency Use Authorization Path Using 3 Minor Groove Binder-Hydrolysis Probe Assays to Detect Escherichia coli O104:H4.
Clin Chem
; 61(11): 1391-8, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26384353
7.
Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus.
Cell Rep Med
; 5(2): 101392, 2024 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38280377
8.
Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates.
Emerg Microbes Infect
; 13(1): 2301061, 2024 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38164768
9.
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus.
Sci Transl Med
; 14(668): eabq0991, 2022 10 26.
Artigo
Inglês
| MEDLINE | ID: mdl-36288283
10.
Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019.
Microorganisms
; 9(3)2021 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33809204
11.
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.
Viruses
; 13(11)2021 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-34835131
12.
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
Sci Rep
; 10(1): 16030, 2020 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32994446
13.
Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak.
Sci Rep
; 10(1): 8724, 2020 05 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32457420
14.
Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.
Sci Rep
; 8(1): 5939, 2018 04 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29651117
15.
Structural basis for antibody-mediated neutralization of Lassa virus.
Science
; 356(6341): 923-928, 2017 06 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28572385
16.
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever.
Nat Med
; 23(10): 1146-1149, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28869611
17.
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies.
Antiviral Res
; 133: 218-222, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27531367
18.
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.
Nat Commun
; 7: 11544, 2016 05 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27161536
19.
Evaluation of ViroCyt® Virus Counter for rapid filovirus quantitation.
Viruses
; 7(3): 857-72, 2015 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-25710889